Trials / Conditions / Primary Mediastinal B-cell Lymphoma (PMBCL)
Primary Mediastinal B-cell Lymphoma (PMBCL)
5 registered clinical trials studyying Primary Mediastinal B-cell Lymphoma (PMBCL) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy NCT07463781 | Fondazione Italiana Linfomi - ETS | — |
| Recruiting | Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma NCT06464861 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 1 |
| Recruiting | DALY II USA/ MB-CART2019.1 for DLBCL NCT04792489 | Miltenyi Biomedicine GmbH | Phase 2 |
| Active Not Recruiting | ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) NCT04049513 | Malaghan Institute of Medical Research | Phase 1 |
| Completed | Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgk NCT02348216 | Kite, A Gilead Company | Phase 1 / Phase 2 |